In vitro selection and identification of ssDNA aptamers recognizing the Ras protein

Zhiwei Wang, Hongbing Wu, Z. Mao, Xiao Hu, Hao Zhang, Zhipeng Hu, Zong-Li RenMolecular 2014 · DOI

Abstract

The aim of this study was to develop high-affinity single-stranded DNA (ssDNA) aptamers that can selectively recognize the protein Ras and can be used as preventive and therapeutic agents for restenosis occurring after coronary surgery or angioplasty. For this purpose, we used the systematic evolution of ligands by exponential enrichment (SELEX) technique, also known as in vitro selection. Using this technique, ssDNA aptamers recognizing the Ras protein were obtained from a synthesized random ssDNA library in vitro. The binding rate and affinity of each aptamer pool, isolated in successive rounds of selection, were measured using ELISA, and the finally selected aptamer pool was cloned and sequenced. The binding affinities of each aptamer in this pool were measured. Their primary and secondary structures were analyzed using the DNAMAN 5.29 software, and the relationship between these structures and corresponding binding affinities was analyzed. The rate of aptamer pool binding to the Ras protein gradually increased from 2.4 to 34.5% along the selection process. Optical density (OD) and equilibrium dissociation constant (Kd) measurements showed that OD gradually increased from 0.220 to 1.080 and Kd decreased from 51.5 to 18.3 nM. The 11th pool of aptamers was selected based on these analyses, and cloning and sequencing of individual aptamers was performed. Secondary structure analysis revealed different conformations, but of a single type: stem‑loop. The aptamer Ra1 showed the highest affinity, with a measured OD of 1.213 and an estimated Kd of 15.3 nM. The binding affinity of the aptamer Ra1 to Ras was dose-dependent. In conclusion, high‑affinity ssDNA aptamers recognizing the Ras protein have been successfully selected. These aptamers may serve in the future as preventive and/or therapeutic agents for restenosis occurring after coronary surgery or angioplasty.

Introduction

Restenosis, the re-narrowing of arteries following coronary angioplasty or bypass surgery, is a major clinical complication driven by the over-proliferation and migration of vascular smooth muscle cells (VSMCs). At the center of this pathological process is the Ras protein, a critical signaling hub that activates growth and migration pathways such as MAPK and PI3K/Akt. While Ras is a prime therapeutic target, it is notoriously difficult to inhibit with traditional antibodies due to their large size and poor cellular penetration. This study investigates the use of single-stranded DNA (ssDNA) aptamers—short nucleic acids that fold into specific 3D shapes—as high-affinity "chemical antibodies" to selectively target the Ras protein and potentially prevent restenosis.

Methods

SELEX Process

The researchers employed the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) process to identify high-affinity binders. The starting point was a synthesized library of 78-bp ssDNA molecules containing a 35-nucleotide random region, representing a vast diversity of potential structural conformations. Over 11 iterative rounds, the library was exposed to recombinant human H-Ras protein. Non-binding sequences were removed, while binders were eluted and amplified via PCR for subsequent rounds.

PCR Optimization

A critical technical hurdle in SELEX is ensuring the specific amplification of the binding pool without introducing molecular noise or non-specific by-products. The authors performed extensive optimization of PCR conditions, adjusting annealing temperatures and cycle counts to maintain library integrity.

Optimization of PCR conditions (annealing temperature and cycle number) for the ssDNA library to ensure specific amplification of the aptamer pool.

Characterization and Structural Analysis

The 11th-round pool was cloned and sequenced, resulting in 50 individual ssDNA sequences. Binding kinetics were measured using ELISA to determine the equilibrium dissociation constant ($K_d$). Secondary structures were predicted using DNAMAN 5.29 software to correlate structural motifs with binding affinity. Mutation analysis was also performed on the predicted binding loops to confirm their role in target recognition.

Results

Enrichment of High-Affinity Binders

The selection process successfully increased the binding rate of the DNA pool to the Ras protein from 2.4% in the first round to 34.5% by the eleventh. This enrichment was reflected in the pool's affinity, with the $K_d$ decreasing from 51.5 nM to 18.3 nM over the course of the experiment.

Identification of Lead Aptamer Ra1

Among the individual sequences identified, the aptamer Ra1 emerged as the most potent binder, with a $K_d$ of 15.3 nM. ELISA analysis confirmed that the binding of Ra1 to the Ras protein is dose-dependent, a key characteristic for potential pharmaceutical applications.

Structural Convergence on Stem-Loops

Secondary structure analysis revealed that despite sequence diversity, the high-affinity aptamers converged on a characteristic stem-loop architecture. The study found that aptamers with more complex or multiple small stem-loops generally exhibited higher binding affinities. Mutation of the terminal loops in Ra1 significantly reduced its binding capacity, confirming these regions as the primary interaction sites with the Ras protein.

Discussion

This study successfully demonstrates the in vitro selection of high-affinity ssDNA aptamers targeting the Ras protein. The lead candidate, Ra1, shows significant promise due to its strong, dose-dependent binding and defined structural motifs. However, several challenges remain before clinical translation. Future research must evaluate the ability of these aptamers to inhibit Ras signaling within living VSMCs and address the engineering challenges associated with delivering nucleic acid therapeutics to the vessel wall in vivo. Nonetheless, these aptamers provide a robust foundation for developing novel preventive agents for post-surgical restenosis.

Summary updated

Abstract

The aim of this study was to develop high-affinity single-stranded DNA (ssDNA) aptamers that can selectively recognize the protein Ras and can be used as preventive and therapeutic agents for restenosis occurring after coronary surgery or angioplasty. For this purpose, we used the systematic evolution of ligands by exponential enrichment (SELEX) technique, also known as in vitro selection. Using this technique, ssDNA aptamers recognizing the Ras protein were obtained from a synthesized random ssDNA library in vitro. The binding rate and affinity of each aptamer pool, isolated in successive rounds of selection, were measured using ELISA, and the finally selected aptamer pool was cloned and sequenced. The binding affinities of each aptamer in this pool were measured. Their primary and secondary structures were analyzed using the DNAMAN 5.29 software, and the relationship between these structures and corresponding binding affinities was analyzed. The rate of aptamer pool binding to the Ras protein gradually increased from 2.4 to 34.5% along the selection process. Optical density (OD) and equilibrium dissociation constant (Kd) measurements showed that OD gradually increased from 0.220 to 1.080 and Kd decreased from 51.5 to 18.3 nM. The 11th pool of aptamers was selected based on these analyses, and cloning and sequencing of individual aptamers was performed. Secondary structure analysis revealed different conformations, but of a single type: stem‑loop. The aptamer Ra1 showed the highest affinity, with a measured OD of 1.213 and an estimated Kd of 15.3 nM. The binding affinity of the aptamer Ra1 to Ras was dose-dependent. In conclusion, high‑affinity ssDNA aptamers recognizing the Ras protein have been successfully selected. These aptamers may serve in the future as preventive and/or therapeutic agents for restenosis occurring after coronary surgery or angioplasty.
BibTeX
@inproceedings{wang2014vitro,
  author = {Zhiwei Wang and Hongbing Wu and Z. Mao and Xiao Hu and Hao Zhang and Zhipeng Hu and Zong-Li Ren},
  title = {{In vitro selection and identification of ssDNA aptamers recognizing the Ras protein}},
  booktitle = {Molecular},
  year = {2014},
  doi = {10.3892/mmr.2014.2337},
}
Figure